Advanced Depression Treatment in Tempe, Arizona
Spravato Treatment in Tempe, Arizona
When depression hasn't responded to traditional treatment, there may be another path.
Alevea Mental Health provides medically supervised SPRAVATO® treatment in Tempe, Arizona, for eligible adults with treatment-resistant depression. Our clinic serves patients throughout Tempe and the greater Phoenix metropolitan area.
Private request • No obligation • Treatment requires a clinical evaluation
Private outpatient care
A calm, medically supervised next step at Alevea.
Evaluation, monitoring, and follow-up all begin with one private request.
When Traditional Depression Treatment Hasn’t Been Enough
Treatment-resistant depression generally refers to depression that has not improved adequately after appropriate antidepressant treatment attempts. A clinician must review the person’s diagnosis, medication history, medical considerations, and previous response to treatment. It does not mean someone has failed, and this page is not a diagnostic tool.
Clinical Evaluation
Who May Be Eligible for Spravato Treatment?
Possible eligibility is determined through an individualized clinical evaluation—not an online checklist. An Alevea psychiatric provider reviews the information needed to decide whether further evaluation makes sense.
- Adult age and a confirmed depressive disorder
- Prior antidepressant treatment history and response
- Medical history, blood pressure, and current medications
- Substance-use, misuse, and other safety considerations
- Ability to remain at the clinic for required monitoring
- Reliable transportation home after each treatment visit
- Insurance medical-necessity criteria when coverage is requested
Meeting one or more general considerations does not establish eligibility. Clinical appropriateness and insurance authorization are separate decisions.
What Is Spravato?
SPRAVATO® is the brand name for esketamine, a prescription nasal spray with FDA-approved indications for certain adults with depression. It works differently from traditional antidepressants and requires a clinical evaluation before it can be prescribed.
SPRAVATO is not dispensed for at-home use. Patients self-administer the medication under direct observation in a certified healthcare setting and remain in the clinic for medical monitoring after each treatment.
How It Works at Alevea
How Spravato Treatment Works at Alevea
Every step is designed to help you understand what may be appropriate before treatment decisions are made.
Request a private review
Tell us how to contact you and provide basic insurance information.
Benefits and eligibility review
Our team will investigate available benefits and discuss the information needed for a clinical evaluation.
Clinical consultation
An Alevea provider will review treatment history, medical considerations, risks, benefits, and whether treatment may be appropriate.
Authorization and treatment
If clinically appropriate and authorized when required, our team will help coordinate treatment and explain what to expect.
What to Expect During a Treatment Visit
Treatment takes place at Alevea’s Tempe clinic. Staff complete a baseline assessment before the medication is self-administered under direct supervision. Blood pressure, respiratory status, and clinical status are assessed, and patients remain for monitoring for at least two hours.
Patients must arrange transportation home and should not drive or operate machinery until the next day after a restful sleep, consistent with prescribing guidance. Treatment frequency is individualized according to clinical recommendations, response, tolerability, and the FDA-approved prescribing information.
Arrive and check in
Baseline assessment
Medication administered under supervision
Monitored treatment period
Discharge with arranged transportation
Treatment Experience
In-office treatment remains structured, supervised, and safety-focused.
Why Choose Alevea for Spravato Treatment?
Alevea connects advanced depression treatment with a broader psychiatric care team, in-office monitoring, insurance support, and ongoing coordination.
Learn more about psychiatric medication management, compare ketamine therapy at Alevea, or request a psychiatric consultation. You can also review Alevea's broader Spravato program information.
Does Insurance Cover Spravato?
Coverage varies by insurer and plan. Prior authorization is often required, and medical-necessity criteria may include documentation of previous medication trials. Alevea can investigate available benefits and explain the insurer’s stated requirements.
Deductibles and copays vary. Verification is not a guarantee of payment, and insurance authorization does not replace the clinician’s separate decision about whether treatment may be appropriate.
Commercial Plans Our Team Can Review
Spravato Versus Ketamine
SPRAVATO and IV ketamine are related but distinct treatment options. A psychiatric evaluation is needed to discuss their different evidence, risks, administration requirements, and insurance considerations.
| Comparison | SPRAVATO | IV ketamine |
|---|---|---|
| Medication | Esketamine | Racemic ketamine |
| Administration | Intranasal, self-administered under observation | Intravenous infusion administered by clinical staff |
| FDA status | Has FDA-approved indications for certain adults with depression | Commonly provided off-label for psychiatric conditions |
| Treatment setting | Certified healthcare setting under SPRAVATO REMS requirements | Clinical infusion setting |
| Insurance | Coverage may be available with plan criteria and prior authorization | Coverage varies and is often limited for psychiatric use |
| Evaluation | Individual clinical evaluation required | Individual clinical evaluation required |
| Monitoring | At least two hours after administration | Monitoring is determined by the clinical protocol and patient needs |
One treatment is not universally better than the other. An Alevea provider can discuss which options, if any, warrant further evaluation.
Learn More about Spravato
Learn about the mechanism of action and how Spravato works. Its precise antidepressant mechanism is not fully understood; SPRAVATO is an NMDA-receptor antagonist that acts through a different pathway than traditional antidepressants.
Accessible video summary and key points
SPRAVATO contains esketamine. It is an NMDA-receptor antagonist that affects glutamate signaling, although the precise mechanism responsible for its antidepressant effect is unknown.
The video explains how this pathway differs from traditional antidepressants. The biological pathway described is a proposed mechanism and does not predict how quickly or how well an individual patient will respond.
The YouTube player loads only after you select play. Playing the video connects to YouTube and may be subject to YouTube's privacy and cookie practices.
Local Care
Spravato Treatment Near Phoenix
Alevea Mental Health provides in-office treatment and monitoring at its Tempe clinic. Patients visit Alevea’s Tempe clinic from communities throughout the East Valley and Phoenix metro area, including Scottsdale, Mesa, Chandler, Gilbert, and Phoenix.
Alevea Mental Health
2034 E Southern Ave, Suite D
Tempe, AZ 85282
Monday-Friday, 9:00 AM-4:00 PM
(480) 923-6200Plan your visit to Alevea
Treatment visits require arranged transportation home. Call the office if you have questions about arrival, accessibility, or transportation planning.
Get directions to the Tempe clinicFrequently Asked Questions
Frequently Asked Questions About Spravato
Direct answers about eligibility, insurance, appointment length, safety, and beginning treatment at Alevea.
Let’s find out whether an evaluation makes sense.
Complete a brief, private request. Alevea’s team will contact you, review basic eligibility considerations, and investigate your insurance benefits.
No obligation. No guarantee of eligibility, treatment, authorization, or coverage.
Private Request
Request a Private Eligibility & Insurance Review
Provide your contact and insurance information. An Alevea team member will reach out to discuss possible next steps.
We only ask for basic contact and insurance details on this page.
Submitting this request does not establish a provider-patient relationship or guarantee treatment.
In-office treatment and monitoring take place in Tempe, Arizona.
Sources and References
Medical and safety statements on this page are supported by official labeling and safety-program resources. Links open the authoritative source.
SPRAVATO® is a prescription medication administered only in a certified healthcare setting. It can cause sedation, dissociation, respiratory depression, increased blood pressure, and misuse or abuse. Patients must be monitored for at least two hours after administration. Treatment requires medical evaluation and is not appropriate for everyone.